Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free

New Upgrade:   Dedicated Screeners for Stocks & ETFs

Learn more

Xylem Reports Third Quarter 2026 Results and Announces Strategic Actions to Accelerate Growth

By Business Wire | October 27, 2026, 6:55 AM
  • Strong orders and backlog, solid earnings performance and margin expansion reflect operational excellence despite a more cautious spending environment
  • Company accelerates transformation strategy, announces intent to divest Applied Water International and Specialty Flow Control; and move to three segment structure in 2027

WASHINGTON--(BUSINESS WIRE)--#LetsSolveWater--Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today reported third-quarter 2026 results and announced actions to further accelerate its portfolio transformation.



While revenue was impacted by project timing and more cautious spending decisions, strong order activity and solid earnings performance demonstrated the resilience of the business and the benefits of the company’s transformation. Xylem also announced its intent to divest Applied Water International and Specialty Flow Control, and beginning in 2027, the alignment of its businesses from four segments to three.

Third Quarter Results

Highlights:

  • Orders of $2.3 billion, up 7% on a reported basis and 10% organically
  • Revenue of $2.2 billion, down 3% on a reported basis and flat organically
  • Earnings per share of $1.25, up 34%; $1.44 on an adjusted basis, up 5%

Third quarter results reflected a mixed operating environment. The company delivered total revenue of $2.2 billion against a dynamic backdrop. Third-quarter earnings per share were up 34 percent on a reported basis and 5 percent on an adjusted basis.

Net income attributable to Xylem for the quarter was $291 million, or $1.25 per share. Net income margin increased 320 basis points to 13.2 percent. These results are primarily driven by strong operational performance and lower loss on sale of businesses, partially offset by increased interest and income tax expense. Adjusted net income attributable to Xylem was $336 million, or $1.44 per share, which excludes purchase accounting intangible amortization, loss on sale of businesses, restructuring and realignment costs, and special charges, including the impact of IEEPA tariff refunds.

Third-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 23.9 percent, reflecting a year-over-year increase of 70 basis points. Productivity savings and strong price realization drove the margin expansion, exceeding the impact of inflation, lower volumes, and mix.

Outlook

Xylem now forecasts full-year 2026 revenue of approximately $8.95 billion, down 1 percent year over year on a reported basis, versus prior guidance of up 2 percent, and flat on an organic basis, versus prior guidance of up 2 to 3 percent.

Full-year 2026 adjusted EBITDA margin is expected to be approximately 23.2 percent, an increase of 100 basis points versus Xylem’s 2025 adjusted results. This results in full-year adjusted earnings per share of $5.40 to $5.45, down from the previous guidance range of $5.55 to $5.70. Full-year free cash flow margin is expected to be approximately 10.2 percent, versus 10.2 to 11.0 percent previously guided.

Further 2026 planning assumptions are included in Xylem’s third-quarter 2026 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Supplemental information on Xylem’s third-quarter earnings, as well as definitions of and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

Sharpening Xylem’s Focus for Growth

Xylem's planned divestiture of Applied Water International and Specialty Flow Control and its move to a three-segment structure are designed to create a more focused company aligned around customer needs and long-term growth priorities.

The planned divestitures further sharpen Xylem’s focus, enabling the company to direct capital toward the technologies, capabilities and markets that align most closely with its long-term strategy. Xylem is already seeing momentum in high-growth industry verticals, including data centers and microelectronics, reinforcing the opportunity to increase investment and exposure in these markets.

Beginning January 1, 2027, Xylem will align its business into three segments: Treatment and Services, Flow Solutions, and Measurement and Analytics. The new structure brings together complementary technologies and capabilities around the core activities of moving water, treating water, and measuring and optimizing water systems. By bringing together businesses with shared customers, technologies and growth opportunities, Xylem expects to unlock greater value across the portfolio and operate with greater simplicity, speed and accountability. Treatment and Services will be led by Rodney Aulick; Flow Solutions will be led by Joe Johnston; and Measurement and Analytics will be led by Meredith Emmerich.

“We’re moving with urgency to shape Xylem around the markets where our capabilities can deliver the greatest customer value and strongest long-term growth," said Matthew Pine, president and CEO of Xylem. "The resilience we’ve built, evident this quarter, allows us to make those choices deliberately and from a position of strength.”

About Xylem

Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Let’s Solve Water.

Xylem uses our Investor Relations website, www.xylem.com/investors, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “contemplate,” “predict,” “forecast,” “likely,” “believe,” “target,” “goal,” “objective,” “will,” “could,” “would,” “should,” “potential,” “may” and similar expressions or their negative, may, but are not necessarily to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector demand and spending, interest rates, availability of funding to our customers, timing of customers’ capital spending and project deployments, inflation and governments' related monetary policy in response, and the strength of the real estate markets, on economic activity and our operations; geopolitical matters, including nationalism, protectionism and anti-global sentiment, volatility involving the U.S. and other governments, ongoing, escalation or outbreak of international conflicts, and regulatory, trade protection, economic and other risks associated with our global sales and operations; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, labor shortages, trade agreements, tariffs, and other trade protection measures, and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents, data breaches, or other disruptions of information technology systems on which we or our customers rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including semiconductors or other key components; operational disruptions at our facilities or that of third parties upon which we rely; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including as respects performance guarantees and customers’ budgets, timelines and safety requirements; our ability to retain, compete for, and attract leadership, other key talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around productivity, simplification, restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth and portfolio optimization actions, including acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, volatile weather events, or changing climate patterns; risks related to our sustainability efforts and related disclosures; fluctuations in foreign currency exchange rates; our level of indebtedness, including debt incurred to finance the pending Cornell Pump and Roper Pump acquisition; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; failure to comply with, or changes in, laws or regulations, pertaining to our business conduct, operations, products and services, including anti-corruption, artificial intelligence, data privacy and security, trade, competition, the environment, and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).

All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

 

 

Three Months

 

Nine Months

For the periods ended September 30,

2026

 

2025

 

2026

 

2025

Revenue from products

$

1,807

 

 

$

1,867

 

 

$

5,517

 

 

$

5,487

 

Revenue from services

 

394

 

 

 

401

 

 

 

1,145

 

 

 

1,151

 

Revenue

 

2,201

 

 

 

2,268

 

 

 

6,662

 

 

 

6,638

 

Cost of revenue from products

 

1,026

 

 

 

1,109

 

 

 

3,176

 

 

 

3,279

 

Cost of revenue from services

 

268

 

 

 

276

 

 

 

813

 

 

 

816

 

Cost of revenue

 

1,294

 

 

 

1,385

 

 

 

3,989

 

 

 

4,095

 

Gross profit

 

907

 

 

 

883

 

 

 

2,673

 

 

 

2,543

 

Selling, general and administrative expenses

 

458

 

 

 

474

 

 

 

1,433

 

 

 

1,437

 

Research and development expenses

 

56

 

 

 

52

 

 

 

171

 

 

 

166

 

Restructuring and asset impairment charges

 

8

 

 

 

23

 

 

 

50

 

 

 

70

 

Operating income

 

385

 

 

 

334

 

 

 

1,019

 

 

 

870

 

Interest expense

 

(21

)

 

 

(6

)

 

 

(32

)

 

 

(23

)

Other non-operating income, net

 

6

 

 

 

6

 

 

 

3

 

 

 

13

 

Loss on sale of businesses

 

(5

)

 

 

(37

)

 

 

(17

)

 

 

(47

)

Income before taxes

 

365

 

 

 

297

 

 

 

973

 

 

 

813

 

Income tax expense

 

(77

)

 

 

(71

)

 

 

(235

)

 

 

(196

)

Net income

$

288

 

 

$

226

 

 

$

738

 

 

$

617

 

Net loss attributable to non-controlling interests

 

3

 

 

 

1

 

 

 

9

 

 

 

5

 

Net income attributable to Xylem

$

291

 

 

$

227

 

 

$

747

 

 

$

622

 

Earnings per share:

 

 

 

 

 

 

 

Basic

$

1.25

 

 

$

0.93

 

 

$

3.15

 

 

$

2.56

 

Diluted

$

1.25

 

 

$

0.93

 

 

$

3.14

 

 

$

2.55

 

Weighted average number of shares:

 

 

 

 

 

 

 

Basic

 

232.7

 

 

 

243.5

 

 

 

237.3

 

 

 

243.3

 

Diluted

 

233.0

 

 

 

244.1

 

 

 

237.7

 

 

 

243.9

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in millions)

 

 

September 30,

2026

 

December 31,

2025

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

708

 

 

$

1,479

 

Receivables, less allowances for discounts, returns and credit losses of $58 and $68 in 2026 and 2025, respectively

 

1,965

 

 

 

1,759

 

Inventories

 

1,052

 

 

 

983

 

Prepaid and other current assets

 

227

 

 

 

244

 

Assets held for sale

 

—

 

 

 

176

 

Total current assets

 

3,952

 

 

 

4,641

 

Property, plant and equipment, net

 

1,203

 

 

 

1,159

 

Goodwill

 

8,524

 

 

 

8,332

 

Other intangible assets, net

 

2,220

 

 

 

2,272

 

Other non-current assets

 

1,427

 

 

 

1,230

 

Total assets

$

17,326

 

 

$

17,634

 

LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND STOCKHOLDERS’ EQUITY

Current liabilities:

 

 

 

Accounts payable

$

1,055

 

 

$

1,013

 

Accrued and other current liabilities

 

1,257

 

 

 

1,237

 

Short-term borrowings and current maturities of long-term debt

 

530

 

 

 

534

 

Liabilities held for sale

 

—

 

 

 

72

 

Total current liabilities

 

2,842

 

 

 

2,856

 

Long-term debt, net

 

2,365

 

 

 

1,408

 

Accrued post-retirement benefit obligations

 

295

 

 

 

317

 

Deferred income tax liabilities

 

453

 

 

 

405

 

Other non-current accrued liabilities

 

860

 

 

 

899

 

Total liabilities

 

6,815

 

 

 

5,885

 

Redeemable non-controlling interest

 

239

 

 

 

258

 

Stockholders’ equity:

 

 

 

Common stock — par value $0.01 per share:

 

 

 

Authorized 750.0 shares, issued 260.3 and 259.9 shares in 2026 and 2025, respectively

 

3

 

 

 

3

 

Capital in excess of par value

 

8,801

 

 

 

8,759

 

Retained earnings

 

4,147

 

 

 

3,706

 

Treasury stock – at cost 30.0 shares and 16.3 shares in 2026 and 2025, respectively

 

(2,375

)

 

 

(768

)

Accumulated other comprehensive loss

 

(307

)

 

 

(220

)

Total stockholders’ equity

 

10,269

 

 

 

11,480

 

Non-controlling interest

 

3

 

 

 

11

 

Total equity

 

10,272

 

 

 

11,491

 

Total liabilities, redeemable non-controlling interest, and stockholders’ equity

$

17,326

 

 

$

17,634

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)

 

For the nine months ended September 30,

2026

 

2025

Operating Activities

 

 

 

Net income

$

738

 

 

$

617

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation

 

195

 

 

 

201

 

Amortization

 

222

 

 

 

231

 

Share-based compensation

 

39

 

 

 

37

 

Restructuring and asset impairment charges

 

50

 

 

 

70

 

Loss from sale of businesses

 

17

 

 

 

47

 

Other, net

 

(32

)

 

 

3

 

Payments for restructuring

 

(59

)

 

 

(48

)

Changes in assets and liabilities (net of acquisitions):

 

 

 

Changes in receivables

 

(201

)

 

 

(113

)

Changes in inventories

 

(72

)

 

 

(30

)

Changes in accounts payable

 

29

 

 

 

(45

)

Changes in accrued and deferred taxes

 

14

 

 

 

(12

)

Changes in long term receivables

 

(147

)

 

 

(108

)

Other, net

 

(64

)

 

 

(152

)

Net Cash — Operating activities

 

729

 

 

 

698

 

Investing Activities

 

 

 

Capital expenditures

 

(268

)

 

 

(248

)

Acquisitions of businesses, net of cash acquired

 

(425

)

 

 

(113

)

Proceeds from sale of businesses, net of cash disposed

 

95

 

 

 

48

 

Proceeds from the sale of property, plant and equipment

 

12

 

 

 

15

 

Cash received from investments

 

8

 

 

 

5

 

Cash paid for investments

 

(10

)

 

 

(26

)

Cash paid for equity investments

 

(4

)

 

 

(5

)

Cash paid for asset acquisition

 

(2

)

 

 

(37

)

Cash received from cross-currency swaps

 

39

 

 

 

31

 

Other, net

 

1

 

 

 

1

 

Net Cash — Investing activities

 

(554

)

 

 

(329

)

Financing Activities

 

 

 

Short-term debt issued, net

 

4

 

 

 

8

 

Short-term debt repaid

 

(5

)

 

 

(7

)

Long-term debt issued, net

 

990

 

 

 

—

 

Long-term debt repaid, net

 

(10

)

 

 

(60

)

Repurchase of common stock

 

(1,580

)

 

 

(14

)

Proceeds from exercise of employee stock options

 

3

 

 

 

11

 

Dividends paid

 

(307

)

 

 

(293

)

Other, net

 

(30

)

 

 

(27

)

Net Cash — Financing activities

 

(935

)

 

 

(382

)

Effect of exchange rate changes on cash

 

(23

)

 

 

83

 

Increase in cash classified within assets held for sale

 

—

 

 

 

(11

)

Decrease in cash classified within assets held for sale

 

12

 

 

 

11

 

Changes in cash classified within assets held for sale

 

12

 

 

 

—

 

Net change in cash and cash equivalents

 

(771

)

 

 

70

 

Cash and cash equivalents at beginning of year

 

1,479

 

 

 

1,121

 

Cash and cash equivalents at end of period

$

708

 

 

$

1,191

 

Supplemental disclosure of cash flow information:

 

 

 

Cash paid during the year for:

 

 

 

Interest

$

39

 

 

$

43

 

Income taxes (net of refunds received)

$

221

 

 

$

208

 

Xylem Inc. Non-GAAP Measures
 
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures that we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.
 
“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
 
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
 
"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
 
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income attributable to Xylem and earnings per share attributable to Xylem, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
 
"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
 
“Free Cash Flow” defined as net cash from operating activities, less capital expenditures, as reported in the Statement of Cash Flows. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt.
 
"Free Cash Flow Margin" defined as free cash flow, adjusted (as applicable) for significant cash paid or received for non-operational tax, acquisition or divestiture activities; divided by revenue.
 
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
 
“Special charges" defined as non-recurring costs incurred by the Company, such as those related to acquisitions and integrations, divestitures non-cash impairment charges and other special charges. In 2026, these charges include reductions of expense related to the refunds of certain tariffs previously imposed under the International, Emergency Economic Powers Act ("IEEPA").
 
“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic Orders ($ Millions)
 

(As Reported)

 

(As Adjusted - Organic)

 

 

(A)

 

(B)

 

 

 

 

 

(C)

 

(D)

 

(E)

 

(F) = B+C+D+E

 

(G) = F/(A-D)

 

 

 

 

Change

 

% Change

 

 

 

Acquisitions

 

Divestitures

 

 

 

Change

 

% Change

Orders

 

Orders

 

2026 v. 2025

 

2026 v. 2025

 

Book-to-Bill

 

 

 

FX Impact

 

Adj. 2026 v. 2025

 

Adj. 2026 v. 2025

2026

 

2025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30
Xylem Inc.

7,645

6,513

1,132

 

17

%

115

%

(38

)

102

(115

)

1,081

 

17

%

Water Infrastructure

2,019

1,981

38

 

2

%

105

%

(23

)

12

(47

)

(20

)

(1

%)

Applied Water

1,552

1,419

133

 

9

%

108

%

-

 

10

(20

)

123

 

9

%

Measurement and Control Solutions

1,409

1,285

124

 

10

%

97

%

(4

)

80

(14

)

186

 

15

%

Water Solutions and Services

2,665

1,828

837

 

46

%

145

%

(11

)

-

(34

)

792

 

43

%

 
Quarter Ended September 30
Xylem Inc.

2,331

2,181

150

 

7

%

106

%

(11

)

74

(4

)

209

 

10

%

Water Infrastructure

675

683

(8

)

(1

%)

105

%

(2

)

4

(2

)

(8

)

(1

%)

Applied Water

502

445

57

 

13

%

103

%

-

 

10

-

 

67

 

15

%

Measurement and Control Solutions

504

446

58

 

13

%

116

%

(4

)

60

-

 

114

 

30

%

Water Solutions and Services

650

607

43

 

7

%

103

%

(5

)

-

(2

)

36

 

6

%

 
Quarter Ended June 30
Xylem Inc.

3,086

2,174

912

 

42

%

132

%

(15

)

23

(41

)

879

 

41

%

Water Infrastructure

669

672

(3

)

(0

%)

98

%

(13

)

3

(13

)

(26

)

(4

%)

Applied Water

538

488

50

 

10

%

107

%

-

 

-

(5

)

45

 

9

%

Measurement and Control Solutions

430

437

(7

)

(2

%)

85

%

-

 

20

(3

)

10

 

2

%

Water Solutions and Services

1,449

577

872

 

151

%

225

%

(2

)

-

(20

)

850

 

147

%

 
Quarter Ended March 31
Xylem Inc.

2,228

2,158

70

 

3

%

105

%

(12

)

5

(70

)

(7

)

(0

%)

Water Infrastructure

675

626

49

 

8

%

112

%

(8

)

5

(32

)

14

 

2

%

Applied Water

512

486

26

 

5

%

114

%

-

 

-

(15

)

11

 

2

%

Measurement and Control Solutions

475

402

73

 

18

%

94

%

-

 

-

(11

)

62

 

15

%

Water Solutions and Services

566

644

(78

)

(12

%)

100

%

(4

)

-

(12

)

(94

)

(15

%)


Contacts

Media
Press Office +1 (978) 704-5149
PressOffice@xylem.com

Investors
Greg Giometti
Michael Travers
Investor.Relations@xylem.com


Read full story here

Mentioned In This Article

Latest News